ACR Highlight for Michael Nissen and SCQM

by Albana Rexhepaj last modified 2011-12-21 11:32

The abstract of Prof. Michael Nissen was selected as one of the highlights of American Collage of Rheumatology (ACR) annual conference 2011! His findings support the current recomandation that DMARD co-therapy provides no additional benefit over anti-TNF monotherapy in SpA.

To read Prof. Graeme Jones’ review of Michael Nissen’s abstract, please scroll to the last page of his ACR conference abstracts review.